In patients at increased risk for the development of renal impairment (e.g., the elderly), renal function should be assessed more frequently
Although shown to have good results, at present, authorities such as the FDA have approved GLP-1 medicines only as injections or tablets, not patches
A standard multivitamin within RDA limits may be considered if dietary intake is insufficient, but supplements should ideally target confirmed deficiencies identified through blood tests
Notably, several ongoing phase II and phase III clinical trials are examining the effects of exenatide, exendin-4, semaglutide, and two novelty drugsPT320 and NLY01on the progression of PD
The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
Foundayo has not been approved for type 2 diabetes